Building a novel occupational rehabilitation program to support cancer survivors to return to health, wellness, and work in Australia.


Journal

Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557

Informations de publication

Date de publication:
02 2020
Historique:
received: 09 07 2019
accepted: 15 10 2019
pubmed: 13 11 2019
medline: 24 9 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

With a substantial increase in the population of cancer survivors of working age, issues concerning sustainable employment must be addressed. The health benefits of work are well established; however, the lack of support to transition back to work is a gap in survivorship care. Researchers, occupational rehabilitation and insurance sectors, cancer support services, and consumers have collaborated to develop a tailored, multimodal occupational rehabilitation program to support resumption of meaningful work for cancer survivors. This paper describes intervention development and refinement based on pilot results and expert- and consumer-recommendations. The pilot was conducted within the life insurance sector, a collaboration fostered by global reinsurance company Swiss Re, with cancer survivors referred to an Australian provider of occupational rehabilitation services. Preliminary outcomes from 15 of 72 cancer survivors following adequate engagement (excluding those who withdrew or were still actively engaged) showed 10 (67%) with improved certified capacity to work, translating to 13 (87%) with improved work status. Consultant survey results indicated barriers to participation in and engagement with the program, including referral delays, health concerns, and cancer recurrence. Expert panel recommendations were used to refine the intervention and tailor to breast cancer survivors for the feasibility stage. Strengths include an innovative model of referral and funding, through a life insurance provider, the involvement of a multidisciplinary collaborative team to design, develop and implement the pilot, and considerable consumer involvement. The refined intervention will address a critical gap to improve reintegration into work and society, contributing to improved quality of life for cancer survivors in Australia. Models of referral through insurers to rehabilitation services could be adopted in other jurisdictions.

Identifiants

pubmed: 31713100
doi: 10.1007/s11764-019-00824-3
pii: 10.1007/s11764-019-00824-3
doi:

Banques de données

ANZCTR
['ACTRN12618001985279']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

31-35

Références

J Natl Cancer Inst. 2018 Dec 1;110(12):1300-1310
pubmed: 30496448
Cancer. 2013 Jun 1;119 Suppl 11:2151-9
pubmed: 23695927
Psychooncology. 2019 Apr;28(4):792-798
pubmed: 30720242
J Cancer Surviv. 2010 Dec;4(4):415-37
pubmed: 20945110
Eur J Cancer Care (Engl). 2007 Jan;16(1):17-25
pubmed: 17227349
J Cancer Surviv. 2014 Jun;8(2):173-82
pubmed: 24464639

Auteurs

D M Sheppard (DM)

Monash University Accident Research Centre, Monash University, Building 70, 21 Alliance Way, Clayton, VIC, 3800, Australia.

D Frost (D)

MedHealth Group, Level 10/451 Little Bourke St, Melbourne, VIC, 3000, Australia.

M Jefford (M)

Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria, 3000, Australia.
Australian Cancer Survivorship Centre, a Richard Pratt legacy, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, Victoria, 3000, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3010, Australia.

M O'Connor (M)

School of Psychology, Curtin University, Kent St, Bentley, WA, 6102, Australia.

G Halkett (G)

School of Nursing, Midwifery and Paramedicine, Curtin University, Kent St, Bentley, WA, 6102, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH